Investor's Business Daily on MSN
Bristol Myers reports surprise sales growth, but there's a caveat
Shares dipped early Thursday. The drugmaker unexpectedly reported sales growth, but its biggest growth driver missed.
By Michael Erman April 30 (Reuters) - Bristol Myers Squibb reported a first-quarter profit that beat Wall Street expectations ...
Bristol Myers Squibb Co.’s quarterly profit and sales beat Wall Street’s expectations, a sign of strength in the drugmaker’s ...
(BMY) stock gains after the company reported better-than-expected Q1 2026 financials and reaffirmed its full-year outlook.
Bristol-Myers Squibb reported first-quarter earnings and revenue that topped analyst expectations, and reaffirmed its outlook for the full year.
Bristol Myers Squibb reported a significant first-quarter profit, beating Wall Street predictions, backed by increased demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results